Duke COVID-19 Shared Data and Specimen Repository
Purpose
The purpose of this data repository is to provide a secure and centralized storage location and resource for the collection of essential data and medical specimens, across COVID-19 related protocols at Duke.
Condition
- COVID-19
Eligibility
- Eligible Ages
- All ages
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Criteria
Subjects will be included in this data repository if they meet the enrollment criteria of
any linked/participating IRB-approved protocol, or if they are not enrolled in another
COVID-related study but meet one of the following inclusion criteria:
1. Suspected novel Coronavirus (nCoV) infection (Person Under Investigation) and/or
2. Laboratory proven acute novel Coronavirus (nCoV) infection and/or
3. Primary admitting diagnosis of nCoV infection
Studies will include:
- Any COVID-19 clinical research studies recruiting Duke patients
- Excludes: protocols sharing non-consented EHR data with national/international
repositories and studies that are recruiting community participants
Study Design
- Phase
- Study Type
- Observational [Patient Registry]
- Observational Model
- Cohort
- Time Perspective
- Prospective
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
COVID-19 Patients | Any Duke patient that is being treated for COVID-19. |
Recruiting Locations
Durham, North Carolina 27710
More Details
- NCT ID
- NCT04368234
- Status
- Recruiting
- Sponsor
- Duke University
Detailed Description
The aim of this data repository is to provide a secure and centralized storage location and resource for the collection of core variables of interest, as well as the retaining of relevant patient samples, across COVID-19 related protocols at Duke. The core data variables were in-part selected to specifically match those agreed upon by Academic Medical Centers across the U.S., with the intention of aiding the efficiency and effectiveness of de-identified data reuse for population-level research. An additional benefit is that centralized, shared data storage of demographic and longitudinal variables will reduce subject burden, as many questions will now only need to be asked once, rather than each time a given subject joins another COVID-19 related study at Duke. This shared data and bio-repository project will house all the core data for all patients with COVID-19 (or suspected cases), as well as individual participants ICFs for all other participating COVID-19 studies enrolling Duke patients. Each participating study will have its own separate IRB approved protocol. Samples may be either collected specifically by the protocol, or include left-over clinical samples from the testing and treatment of patients with COVID-19 at Duke.